Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention
2019 ◽
Vol 6
(2)
◽
pp. 175-176
2019 ◽
Vol 8
(22)
◽
2016 ◽
Vol 15
(1)
◽
pp. 51-58
◽
2021 ◽
Vol 77
(18)
◽
pp. 3313
2021 ◽
Vol 77
(18)
◽
pp. 1484
2021 ◽
Vol 235
◽
pp. 113776
2016 ◽
Vol 26
(8)
◽
pp. 521-526
◽